Projects per year
Personal profile
Research Interests
Prof Thakur Raghu Raj Singh is Professor in Pharmaceutics in the School of Pharmacy, Queen's University Belfast. He has obtained his Ph.D. in Drug Delivery from School of Pharmacy, Queens University Belfast (2009), M.Sc in Pharmaceutical Sciences from University Science Malaysia (2006) and B.Pharm from Jawaharlal Nehru Technological University, India (2002).
Prof Thakur’s research interests are in the design and physicochemical characterisation of advanced polymeric drug delivery systems for ocular, transdermal and topical applications. In particular, his current research involves the fabrication and design of novel long-acting injectable and implantable drug delivery systems for treating back of the eye disorders.
His research on the treatment of eye disorders has led to the formation of Re-Vana Therapeutics Ltd., where he is currently serving as a Chief Technical Officer (CTO). Re-Vana Therapeutics is an ocular pharmaceutical & drug delivery company focused on addressing ophthalmic conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and other ocular infections.
He is the Chair for Ocular Delivery (OcD) Focus Group supported by the mission of Controlled Release Society (CRS) that engages researchers, industry representatives, and regulatory experts in the advancement of technologies designed to protect or restore vision. He is Associate Editor for Drug Delivery and Translational Research; Editorial Board member of Advance in Pharmaceutical Sciences; Editorial Board member of Ophthalmic Drug Delivery (specialty section of Frontiers in Drug Delivery); Editorial Board member of the International Journal of Pharmacy & Pharmacology, Chronicles of Pharmacy and SCIENCEDOMAIN international
He has authored over 150 scientific publications, including 54 peer-reviewed research papers, 16 book chapters and 5 textbooks. He has been an invited speaker at a number of national/international meetings.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
R6617PMY: Ocular Research By Integrated Training And Learning
Singh, T. R. R., Donnelly, R. & Larrañeta, E.
03/05/2019 → …
Project: Research
-
R6567PMY: Drug Discovery and Delivery NEtwork for Oncology and Eye Therapeutics
25/04/2017 → …
Project: Research
-
R1526PMY: Development and Preclinical Evaluation of Novel Long-acting Injectable Ocular Implants
22/05/2015 → 30/06/2016
Project: Research
-
R3616PMY: Novel Biomaterials for localised drug delivery for bone regeneration
Migaud, M. & Singh, T. R. R.
21/03/2014 → 15/08/2016
Project: Research
-
Fabrication and characterisation of 3D-printed triamcinolone acetonide-loaded polycaprolactone-based ocular implants
Annuryanti, F., Dominguez Robles, J., Anjani, Q. K., Adrianto, M. F., Larrañeta, E. & Singh, T. R. R., 11 Jan 2023, In: Pharmaceutics. 15, 1, 18 p., 243.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Downloads (Pure) -
Deferasirox nanosuspension loaded dissolving microneedles for intradermal delivery
Faizi, H. S., Vora, L. K., Nasiri, M. I., Wu, Y., Mishra, D., Anjani, Q. K., Paredes, A. J., Thakur, R. R. S., Minhas, M. U. & Donnelly, R. F., 15 Dec 2022, In: Pharmaceutics. 14, 12, 19 p., 2817.Research output: Contribution to journal › Article › peer-review
Open AccessFile16 Downloads (Pure) -
Development and characterization of injectable depot forming thermoresponsive hydrogel for the sustained intrascleral delivery of Sunitinib
Gade, S., Larrañeta, E., Donnelly, R. F., Vanrell, R. H., Alvarez-Lorenzo, C. I. & Thakur, R. R. S., 03 Nov 2022, In: British Journal of Pharmacy. 7, 2, p. S1-S2 2 p., 1175 .Research output: Contribution to journal › Meeting abstract › peer-review
Open AccessFile7 Downloads (Pure) -
Injectable depot forming thermoresponsive hydrogel for sustained intrascleral delivery of sunitinib using hollow microneedles
Gade, S. S., Pentlavalli, S., Mishra, D., Vora, L. K., Waite, D., Alvarez-Lorenzo, C. I., Herrero Vanrell, M. R., Laverty, G., Larrañeta, E., Donnelly, R. F. & Singh Thakur, R. R., 01 Aug 2022, In: Journal of Ocular Pharmacology and Therapeutics. 38, 6, p. 433-448Research output: Contribution to journal › Article › peer-review
-
Microneedles assisted controlled and improved transdermal delivery of high molecular drugs via
Khan, S., Minhas, M. U., Singh Thakur, R. R. & Aqeel, M. T., 05 Aug 2022, In: Drug Development and Industrial Pharmacy. 48, 6, p. 265-278Research output: Contribution to journal › Article › peer-review
Prizes
-
Best Oral Presentation, British Pharmaceutical Conference, Manchester, U.K, September 2008.
Singh, Thakur Raghu Raj (Recipient), 2008
Prize: Prize (including medals and awards)
-
Best Poster Prize at 2nd Microneedle Conference, Cork, Ireland, May 2012.
Singh, Thakur Raghu Raj (Recipient), 2012
Prize: Prize (including medals and awards)
-
Best Poster Prize at Skin forum conference in Versailles, France, March 2009.
Singh, Thakur Raghu Raj (Recipient), 2009
Prize: Prize (including medals and awards)
-
Bets Oral Presentation at Vision TRG Conference
Singh, Thakur Raghu Raj (Recipient), 14 Mar 2014
Prize: Prize (including medals and awards)
-
Business Innovation Award 2022
Singh, Thakur Raghu Raj (Recipient), Oct 2022
Prize: Prize (including medals and awards)
Activities
-
Developing Degradable Implants to Successfully Incorporate Biologic Therapies
Thakur Raghu Raj Singh (Advisor)
Jan 2023 → …Activity: Talk or presentation types › Oral presentation
-
Long-acting Implants for Delivery of Biologics to the Eye
Thakur Raghu Raj Singh (Advisor)
Oct 2022Activity: Talk or presentation types › Oral presentation
-
Long-acting Formulations of Biologics for Ocular Drug Delivery: Challenges and Progress
Thakur Raghu Raj Singh (Advisor)
28 Sep 2022Activity: Talk or presentation types › Oral presentation
-
Sustained and localised drug delivery to the eye using minimally-invasive microneedles
Thakur Raghu Raj Singh (Advisor)
14 Sep 2022Activity: Talk or presentation types › Oral presentation
-
Frontiers in Drug Delivery (External organisation)
Thakur Raghu Raj Singh (Advisor)
2022 → …Activity: Membership types › Membership of board
Press/Media
-
-
-
Re-Vana Therapeutics Raises $3.25 Million in Pre-Series A Financing
02/06/2020
1 Media contribution
Press/Media: Other
-
All eyes on innovation at Glaucoma 360 New Horizons Forum
06/02/2020
1 item of Media coverage
Press/Media: Expert Comment
-
Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board
04/06/2019
1 item of Media coverage
Press/Media: Other